Optimizing BTK Inhibitor Therapy in CLL: Updates and Strategies for Oncology Pharmacists

Enhance your understanding of optimizing BTK inhibitor therapy in chronic lymphocytic leukemia. Learn more about individualizing therapy, monitoring for and managing adverse events, and strategies to address barriers to treatment access and adherence through an on-demand webcast, expert-authored ClinicalThought commentary, audio podcast, and downloadable slides.

Share

Program Content

No activities added yet

Provided by

ProCE Banner
ProCE Banner

Provided by ProCE, LLC in collaboration with Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Lilly.

AstraZeneca

Lilly